Emerging multidrug-resistant Candida species

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · see citing works

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · see citing works

Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · see citing works

<i>Candida auris</i> sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital

Satoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381 · see citing works

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298 · see citing works

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

Cornely, O. A., Arıkan-Akdağlı, S., Dannaoui, É., Groll, A. H., Lagrou, K., Chakrabarti, A., Lanternier, F., Pagano, L., Skiada, A., Akova, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12371 · Cited by 864 · see citing works

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · see citing works

First hospital outbreak of the globally emerging Candida auris in a European hospital

Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance &amp; Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768 · see citing works

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750 · see citing works

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of <i>Candida</i> Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718 · see citing works

Global trends in the distribution of Candida species causing candidemia

Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680 · see citing works

Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method

Kathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F. G. M., & Chowdhary, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00367-15 · Cited by 536 · see citing works

First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris

Lee, W. G., Shin, J. H., Uh, Y., Kang, M. G., Kim, S. H., Park, K. H., & Jang, H. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-11 · Cited by 524 · see citing works

Amphotericin B: spectrum and resistance

Ellis, D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.7 · Cited by 474 · see citing works

First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia

Calvo, B., Melo, A. S. D. A., Mena, A. J. P., Hernandez, M., Francisco, E. C., Hagen, F., Meis, J. F. G. M., & Colombo, A. L. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.07.008 · Cited by 448 · see citing works

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008

Pfaller, M. A., Neofytos, D., Diekema, D. J., Azie, N. E., Meier‐Kriesche, H., Quan, S.-P., & Horn, D. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.10.003 · Cited by 391 · see citing works

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata

Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377 · see citing works

Epidemiology of candidemia in Latin America: a laboratory-based survey

Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I. N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M. E., Thompson, L., Sifuentes-Osornio, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059373 · Cited by 374 · see citing works

Echinocandin resistance in Candida.

Perlin, D. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ791 · Cited by 374 · see citing works

Candida auris candidaemia in Indian ICUs: analysis of risk factors

Rudramurthy, S. M., Chakrabarti, A., Paul, R. A., Sood, P., Kaur, H., Capoor, M. R., Kindo, A. J., Marak, R. S. K., Arora, A., Sardana, R., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx034 · Cited by 357 · see citing works

Candidaemia in Europe: epidemiology and resistance

Tortorano, A. M., Kibbler, C. C., Pemán, J., Bernhardt, H., Klingspor, L., & Grillot, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.01.002 · Cited by 349 · see citing works

Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen <i>Candida auris</i> and Other Key Pathogenic <i>Candida</i> Species

Borman, A. M., Szekely, A., & Johnson, E. M. (2016) · mSphere · doi:10.1128/msphere.00189-16 · Cited by 333 · see citing works

The changing epidemiology of invasive candidiasis

Hachem, R. Y., Hanna, H. A., Kontoyiannis, D. P., Jiang, Y., & RAAD, I. I. (2008) · Cancer · doi:10.1002/cncr.23466 · Cited by 330 · see citing works

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)

The French Mycosis Study Group, Lortholary, O., Renaudat, C., Sitbon, K., Madec, Y., Denoeud‐Ndam, L., Wolff, M., Fontanet, A. L., Bretagne, S., & Dromer, F. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3408-3 · Cited by 310 · see citing works

Candida haemuloniiand Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features

Kim, M., Shin, J. H., Sung, H., Lee, K., Kim, E.-C., Ryoo, N. H., Lee, J., Jung, S., Park, K. H., Kee, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597108 · Cited by 310 · see citing works

Multidrug-Resistant <i>Candida haemulonii</i> and <i>C. auris</i> , Tel Aviv, Israel

Ben-Ami, R., Berman, J., Novikov, A., Bash, E., Shachor-Meyouhas, Y., Zakin, S., Maor, Y., Tarabia, J., Schechner, V., Adler, A., et al. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2302.161486 · Cited by 297 · see citing works

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance.

Healey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276 · see citing works

<i>Candida auris</i>–Associated Candidemia, South Africa

Magobo, R. E., Corcoran, C., Seetharam, S., & Govender, N. P. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.131765 · Cited by 259 · see citing works

Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in <i>Candida glabrata</i>

Sanglard, D., Ischer, F., & Bille, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1174-1183.2001 · Cited by 247 · see citing works

Invasive Infections with Multidrug-Resistant Yeast Candida auris , Colombia

Morales-López, S. E., Parra‐Giraldo, C. M., Ceballos-Garzón, A., Martínez, H. P., Rodríguez, G. J., Álvarez, C., & Rodríguez, J. Y. (2016) · Emerging infectious diseases · doi:10.3201/eid2301.161497 · Cited by 244 · see citing works

Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic Yeasts

Cendejas‐Bueno, E., Kolecka, A., Alastruey‐Izquierdo, A., Theelen, B., Groenewald, M., Kostrzewa, M., Cuenca‐Estrella, M., Gómez‐López, A., & Boekhout, T. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02248-12 · Cited by 234 · see citing works

Pdr1 regulates multidrug resistance in <i>Candida glabrata</i> : gene disruption and genome‐wide expression studies

Vermitsky, J., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D., & Rogers, P. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05235.x · Cited by 233 · see citing works

Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance

Pham, C. D., Iqbal, N., Bolden, C. B., Kuykendall, R. J., Harrison, L. H., Farley, M. M., Schaffner, W., Beldavs, Z. G., Chiller, T. M., Park, B. J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03255-14 · Cited by 231 · see citing works

Can Multidrug-Resistant Candidaauris Be Reliably Identified in Clinical Microbiology Laboratories?

Mizusawa, M., Miller, H., Green, R., Lee, R. E., Jr., Durante, M., Perkins, R., Hewitt, C. M., Simner, P. J., Carroll, K. C., Hayden, R. T., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02202-16 · Cited by 218 · see citing works

Multidrug-resistant Candida auris: ‘New kid on the block’ in hospital-associated infections?

Chowdhary, A., Voss, A., & Meis, J. F. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.08.004 · Cited by 214 · see citing works

A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality

Bassetti, M., Righi, E., Ansaldi, F., Merelli, M., Scarparo, C., Antonelli, M. M., Garnacho‐Montero, J., Díaz‐Martín, A., Palacios-García, I., Luzzati, R., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3866-2 · Cited by 210 · see citing works

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

Arendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206 · see citing works

Candida guilliermondii , an Opportunistic Fungal Pathogen with Decreased Susceptibility to Fluconazole: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program

Pfaller, M. A., Diekema, D. J., Méndez, M., Kibbler, C. C., Erzsebet, P., Chang, S., Gibbs, D. L., Newell, V. A., & the Global Antifungal Surveillance Group (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00865-06 · Cited by 192 · see citing works

Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based Candidemia Surveillance Program, 2008–2014

Vallabhaneni, S., Cleveland, A. A., Farley, M. M., Harrison, L. H., Schaffner, W., Beldavs, Z. G., Derado, G., Pham, C. D., Lockhart, S. R., & Smith, R. M. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv163 · Cited by 187 · see citing works

Candida aurisCandidemia in Kuwait, 2014

Emara, M., Ahmad, S., Khan, Z., Joseph, L., Al-Obaid, I., Purohit, P., & Bafna, R. (2015) · Emerging infectious diseases · doi:10.3201/eid2106.150270 · Cited by 185 · see citing works

Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer

Colombo, A. L., de Almeida, J. N., Slavin, M. A., Chen, S. C. ‐., & Sorrell, T. C. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30304-3 · Cited by 177 · see citing works

FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia

Beyda, N. D., John, J., Kilic, A., Alam, M. J., Lasco, T. M., & Garey, K. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu407 · Cited by 174 · see citing works

The Presence of an <i>FKS</i> Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Shields, R. K., Nguyen, M. H., Press, E. G., Kwa, A. L., Cheng, S., Du, C., & Clancy, C. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00027-12 · Cited by 171 · see citing works

Changing epidemiology of candidaemia in Australia

Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw422 · Cited by 163 · see citing works

Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1 , in Candida glabrata

Miyazaki, H., Miyazaki, Y., Geber, A., Parkinson, T., Hitchcock, C. A., Falconer, D. J., Ward, D. J., Marsden, K. E., & Bennett, J. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1695 · Cited by 162 · see citing works

Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017

Tsay, S. V., Welsh, R. M., Adams, E. H., Chow, N. A., Gade, L., Berkow, E. L., Poirot, E., Lutterloh, E. C., Quinn, M., Chaturvedi, S., et al. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6619a7 · Cited by 160 · see citing works

Nosocomial fungemia by Candida auris: First four reported cases in continental Europe

Gaitán, A. C. R., Moret, A. M., Hontangas, J. L. L., Molina, J. M. R., López, A., Hernández-Cabezas, A., Maseres, J. B. M., Chouman-Arcas, R., Ruiz, M. D. G., Chiveli, M.-A., et al. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.11.002 · Cited by 158 · see citing works

Debaryomyces hansenii ( Candida famata ), a Rare Human Fungal Pathogen Often Misidentified as Pichia guilliermondii ( Candida guilliermondii )

Desnos‐Ollivier, M., Ragon, M., Robert, V., Raoux‐Barbot, D., Gantier, J.-C., & Dromer, F. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01451-08 · Cited by 154 · see citing works

Drug-Resistant<i>Candida glabrata</i>Infection in Cancer Patients

Farmakiotis, D., Tarrand, J. J., & Kontoyiannis, D. P. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2011.140685 · Cited by 152 · see citing works

Changing epidemiology of candidaemia in Australia

Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx047 · Cited by 149 · see citing works

Current perspective on emergence, diagnosis and drug resistance in Candida auris

Sarma, S., & Upadhyay, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s116229 · Cited by 147 · see citing works

Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice

Ferrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-10 · Cited by 144 · see citing works

The ATP‐binding cassette transporter–encoding gene <i>CgSNQ2</i> is contributing to the <i>CgPDR1</i>‐dependent azole resistance of <i>Candida glabrata</i>

Torelli, R., Posteraro, B., Ferrari, S., La Sorda, M., Fadda, G., Sanglard, D., & Sanguinetti, M. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06143.x · Cited by 141 · see citing works

<i>FKS</i> Mutations and Elevated Echinocandin MIC Values among <i>Candida glabrata</i> Isolates from U.S. Population-Based Surveillance

Zimbeck, A. J., Iqbal, N., Ahlquist, A. M., Farley, M. M., Harrison, L. H., Chiller, T., & Lockhart, S. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00836-10 · Cited by 136 · see citing works

<i>Candida</i> spp. with Acquired Echinocandin Resistance, France, 2004–20101

Dannaoui, E., Desnos-Ollivier, M., Garcia-Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., Lortholary, O., & the French Mycoses Study Group (2012) · Emerging infectious diseases · doi:10.3201/eid1801.110556 · Cited by 130 · see citing works

Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011

Guinea, J., Zaragoza, Ó., Escribano, P., Martín‐Mazuelos, E., Pemán, J., Sánchez, F., & Cuenca‐Estrella, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02155-13 · Cited by 129 · see citing works

Abdominal candidiasis is a hidden reservoir of echinocandin resistance

Shields, R. K., Nguyen, M. H., Press, E. G., & Clancy, C. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04134-14 · Cited by 118 · see citing works

A Nonsense Mutation in the <i>ERG6</i> Gene Leads to Reduced Susceptibility to Polyenes in a Clinical Isolate of <i>Candida glabrata</i>

Vandeputte, P., Tronchin, G., Larcher, G., Ernoult, E., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-08 · Cited by 117 · see citing works

Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation in <i>ERG11</i> and Exhibiting Cross-Resistance to Azoles and Amphotericin B

Hull, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06253-11 · Cited by 113 · see citing works

Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005

Zepelin, M. B., Kunz, L., Rüchel, R., Reichard, U., Weig, M., & Groß, U. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm145 · Cited by 109 · see citing works

Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the <i>ERG6</i> Gene in a Clinical Isolate of <i>Candida glabrata</i> with Pseudohyphal Growth

Vandeputte, P., Tronchin, G., Bergès, T., Hennequin, C., Chabasse, D., & Bouchara, J.-P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01510-06 · Cited by 109 · see citing works

Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.

Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00136-13 · Cited by 105 · see citing works

Outbreak of Fungemia among Neonates Caused by Candida haemulonii Resistant to Amphotericin B, Itraconazole, and Fluconazole

Khan, Z. U., Al‐Sweih, N., Ahmad, S., Al-Kazemi, N., Khan, S. I., Joseph, L., & Chandy, R. G. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00222-07 · Cited by 105 · see citing works

Unraveling drug penetration of echinocandin antifungals at the site of infection in an intra-abdominal abscess model

Zhao, Y., Prideaux, B., Nagasaki, Y., Lee, M. H., Chen, P.-Y., Blanc, L., Ho, H., Clancy, C. J., Nguyen, M. H., Dartois, V., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-17 · Cited by 102 · see citing works

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

Castanheira, M., Woosley, L. N., Diekema, D. J., Jones, R. N., & Pfaller, M. A. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01686-12 · Cited by 100 · see citing works

Two new species in the clade: sp. nov., the ascosporic state of , and comb. nov

VAUGHANMARTINI, A., Kurtzman, C. P., MEYER, S., & ONEILL, E. (2004) · FEMS Yeast Research · doi:10.1016/j.femsyr.2004.10.008 · Cited by 95 · see citing works

Genetic Drivers of Multidrug Resistance in Candida glabrata

Healey, K. R., Jimenez Ortigosa, C., Shor, E., & Perlin, D. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01995 · Cited by 93 · see citing works

Two Clinical Isolates of Candida glabrata Exhibiting Reduced Sensitivity to Amphotericin B Both Harbor Mutations in <i>ERG2</i>

Hull, C. M., Bader, O., Parker, J. E., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01145-12 · Cited by 90 · see citing works

First report of Candida auris in Oman: Clinical and microbiological description of five candidemia cases

Al-Siyabi, T., Busaidi, I. A., Balkhair, A., Muharrmi, Z. A., Al-Salti, M., & Adawi, B. A. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.05.016 · Cited by 88 · see citing works

Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil

Ramos, L. S., Figueiredo‐Carvalho, M. H. G., Barbedo, L. S., Ziccardi, M., Chaves, A. L. D. S., Zancopé‐Oliveira, R. M., Pinto, M. R., Sgarbi, D. B. D. G., Dornelas-Ribeiro, M., Branquinha, M. H., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku321 · Cited by 87 · see citing works

What do we know about Candida guilliermondii ? A voyage throughout past and current literature about this emerging yeast

Savini, V., Catavitello, C., Onofrillo, D., Masciarelli, G., Astolfi, D., Balbinot, A., Febbo, F., D’Amario, C., & D’Antonio, D. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01960.x · Cited by 86 · see citing works

The first cases of Candida auris candidaemia in Oman

Mohsin, J., Hagen, F., Al‐Balushi, Z. A. M., de Hoog, S., Chowdhary, A., Meis, J. F. G. M., & Al‐Hatmi, A. M. S. (2017) · Mycoses · doi:10.1111/myc.12647 · Cited by 84 · see citing works

Comparison of the Accuracy of Two Conventional Phenotypic Methods and Two MALDI-TOF MS Systems with That of DNA Sequencing Analysis for Correctly Identifying Clinically Encountered Yeasts

Chao, Q.-T., Lee, T.-F., Teng, S.-H., Peng, L., Chen, P., Teng, L., & Hsueh, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109376 · Cited by 82 · see citing works

Frequency of <i>fks</i> Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Castanheira, M., Woosley, L. N., Messer, S. A., Diekema, D. J., Jones, R. N., & Pfaller, M. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01674-13 · Cited by 82 · see citing works

The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality

Wang, E., Farmakiotis, D., Yang, D., McCue, D. A., Kantarjian, H. M., Kontoyiannis, D. P., & Mathisen, M. S. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv087 · Cited by 82 · see citing works

Candida guilliermondii Fungemia in Patients with Hematologic Malignancies

Girmenia, C., Pizzarelli, G., Cristini, F., Barchiesi, F., Spreghini, E., Scalise, G., & Martino, P. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00356-06 · Cited by 80 · see citing works

Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management

Farmakiotis, D., & Kontoyiannis, D. P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.019 · Cited by 76 · see citing works

Clinical perspectives on echinocandin resistance among Candida species

Shields, R. K., Nguyen, M. H., & Clancy, C. J. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000215 · Cited by 75 · see citing works

Fluconazole and Echinocandin resistance of Candida glabrata correlates better with antifungal drug exposure rather than with MSH2 mutator genotype in a French Cohort of patients harboring low rates of resistance.

Dellière, S., Healey, K., Gits-Muselli, M., Carrara, B., Barbaro, A., Guigue, N., Lecefel, C., Touratier, S., Desnos-Ollivier, M., Perlin, D. S., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02038 · Cited by 75 · see citing works

Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong <i>In Vitro</i> Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds

Schell, W. A., Jones, A. M., Garvey, E. P., Hoekstra, W. J., Schotzinger, R. J., & Alexander, B. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01817-16 · Cited by 74 · see citing works

Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff Values

Pfaller, M. A., Espinel‐Ingroff, A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02441-10 · Cited by 73 · see citing works

Epidemiology and reporting of candidaemia in Belgium: a multi-centre study

Trouvé, C., Blot, S. I., Hayette, M., Jonckheere, S., Patteet, S., Rodriguez‐Villalobos, H., Symoens, F., Wijngaerden, E. V., & Lagrou, K. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2841-3 · Cited by 72 · see citing works

Reliable differentiation of Meyerozyma guilliermondii from Meyerozyma caribbica by internal transcribed spacer restriction fingerprinting

Romi, W., Keisam, S., Ahmed, G., & Jeyaram, K. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-52 · Cited by 70 · see citing works

Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses

Kumar, A., Prakash, A., Singh, A. K., Kumar, H., Hagen, F., Meis, J. F. G. M., & Chowdhary, A. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.49 · Cited by 69 · see citing works

Identification of Uncommon Candida Species Using Commercial Identification Systems

Kim, T., Kweon, O. J., Kim, H. R., & Lee, M. (2016) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1609.09012 · Cited by 69 · see citing works

Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy

Forastiero, A., Garcia-Gil, V., Rivero-Menéndez, O., Garcia‐Rubio, R., Monteiro, M. C., Alastruey‐Izquierdo, A., Jordán, R., Agorio, I., & Mellado, E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01005-15 · Cited by 68 · see citing works

Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

Espinel‐Ingroff, A., Álvarez-Fernández, M., Cantón, R., Carver, P. L., Chen, S. C. A., Eschenauer, G. A., Getsinger, D., González, G. M., Govender, N. P., Grancini, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01250-15 · Cited by 67 · see citing works

Transient Fungemia Caused by an Amphotericin B-Resistant Isolate of Candida haemulonii

Rodero, L., Cuenca‐Estrella, M., Córdoba, S. B., Cahn, P. E., Davel, G., Kaufman, S. C., Guelfand, L. I., & Rodrı́guez-Tudela, J. L. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.2266-2269.2002 · Cited by 65 · see citing works

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010–2012)

Pfaller, M. A., Messer, S. A., Jones, R. N., & Castanheira, M. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.29 · Cited by 64 · see citing works

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

Fekkar, A., Dannaoui, É., Meyer, I., Imbert, S., Brossas, J., Uzunov, M., Mellon, G., Nguyen‐Quoc, S., Guiller, E., Caumes, É., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2096-9 · Cited by 63 · see citing works

Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin

Bizerra, F. C., Jimenez-Ortigosa, C., Souza, A. C. R., Breda, G. L., Queiroz-Telles, F., Perlin, D. S., & Colombo, A. L. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02189-13 · Cited by 63 · see citing works

Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy

Kabbara, N., Lacroix, C., Peffault de Latour, R., Socie, G., Ghannoum, M., & Ribaud, P. (2008) · Haematologica · doi:10.3324/haematol.11149 · Cited by 61 · see citing works

Rapid Detection of <i>FKS</i> -Associated Echinocandin Resistance in Candida glabrata

Zhao, Y., Nagasaki, Y., Kordalewska, M., Press, E. G., Shields, R. K., Nguyen, M. H., Clancy, C. J., & Perlin, D. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-16 · Cited by 61 · see citing works

Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes

Ruan, S., Kuo, Y.-W., Huang, C., Hsiue, E. H.-C., & Hsueh, P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.08.009 · Cited by 59 · see citing works

Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China

Hou, X., Xiao, M., Chen, S. C.-A., Wang, H., Cheng, J., Chen, X., Xu, Z., Fan, X., Kong, F., & Xu, Y. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01492-16 · Cited by 57 · see citing works

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying <i>FKS</i> Mutant Candida glabrata Strains and Echinocandin Resistance

Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-13 · Cited by 56 · see citing works

Candida glabrata fungaemia in intensive care units

Ruan, S., Lee, L., Jerng, J., Yu, C., & Hsueh, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01892.x · Cited by 55 · see citing works

Rate of<i>FKS</i>Mutations among Consecutive Candida Isolates Causing Bloodstream Infection

Shields, R. K., Nguyen, M. H., Press, E. G., Cumbie, R., Driscoll, E., Pasculle, A. W., & Clancy, C. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01973-15 · Cited by 55 · see citing works

Candida haemuloniiComplex Species, Brazil, January 2010–March 2015

de Almeida, J. N., Assy, J. G. P. L., Levin, A. S., Negro, G. M. B. D., Giudice, M. C., Tringoni, M. P., Thomaz, D. Y., Motta, A. L., Abdala, E., Pierrotti, L. C., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2203.151610 · Cited by 55 · see citing works

Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia

Marcos-Zambrano, L. J., Puig‐Asensio, M., Pérez‐García, F., Escribano, P., Sánchez‐Carrillo, C., Zaragoza, Ó., Padilla, B., Cuenca‐Estrella, M., Almirante, B., Martín-Gómez, M. T., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00099-17 · Cited by 54 · see citing works

Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida

Ostrosky‐Zeichner, L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit140 · Cited by 51 · see citing works

Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method

Pfaller, M. A., Espinel‐Ingroff, A., Bustamante, B., Cantón, R., Diekema, D. J., Fothergill, A., Fuller, J., González, G. M., Guarro, J., Lass‐Flörl, C., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02020-13 · Cited by 51 · see citing works

Development of a Luminex-Based Multiplex Assay for Detection of Mutations Conferring Resistance to Echinocandins in Candida glabrata

Pham, C. D., Bolden, C. B., Kuykendall, R. J., & Lockhart, S. R. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03378-13 · Cited by 50 · see citing works

Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria

Klotz, U., Schmidt, D., Willinger, B., Steinmann, E., Buer, J., Rath, P., & Steinmann, J. (2016) · Mycoses · doi:10.1111/myc.12472 · Cited by 49 · see citing works

Echinocandin Resistance in Two Candida haemulonii Isolates from Pediatric Patients

Muro, M. D., Motta, F. D. A., Burger, M., Melo, A. S. D. A., & Dalla-Costa, L. M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01136-12 · Cited by 47 · see citing works

Identification of Candida haemulonii Complex Species: Use of ClinProToolsTM to Overcome Limitations of the Bruker BiotyperTM, VITEK MSTM IVD, and VITEK MSTM RUO Databases

Grenfell, R. C., da Silva, A. R., Negro, G. M. B. D., Munhoz, R. B., Gimenes, V. M. F., Assis, D. M., Rockstroh, A. C., Motta, A. L., Rossi, F., Juliano, L., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00940 · Cited by 44 · see citing works

Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients

Prigent, G., Aït‐Ammar, N., Levesque, É., Fekkar, A., Costa, J., Anbassi, S. E., Foulet, F., Duvoux, C., Merle, J., Dannaoui, É., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01229-16 · Cited by 44 · see citing works

<scp>EUCAST</scp> Technical Note on <i>Candida</i> and micafungin, anidulafungin and fluconazole

Cavling Arendrup, M., Cuenca‐Estrella, M., Lass‐Flörl, C., Hope, W. W., & The European Committee on Antimicrobial Susceptibility Testing – Subcommittee on Antifungal Susceptibility Testing (EUCAST‐AFST) (2014) · Mycoses · doi:10.1111/myc.12170 · Cited by 43 · see citing works

Systematic review and new insights into the molecular characterization of the Candida rugosa species complex

Padovan, A. C. B., Melo, A. S. D. A., & Colombo, A. L. (2013) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2013.10.007 · Cited by 43 · see citing works

Evaluation of Caspofungin Susceptibility Testing by the New Vitek 2 AST-YS06 Yeast Card Using a Unique Collection of <i>FKS</i> Wild-Type and Hot Spot Mutant Isolates, Including the Five Most Common Candida Species

Astvad, K. M., Perlin, D. S., Johansen, H. K., Jensen, R. H., & Arendrup, M. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01382-12 · Cited by 43 · see citing works

Catheter-related Candidemia Caused by Candida haemulonii in a Patient in Long-term Hospital Care

Kim, S., Ko, K. S., Moon, S. Y., Lee, M. S., Lee, M. Y., & Son, J. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.2.297 · Cited by 36 · see citing works

Emergence of multiple resistance profiles involving azoles, echinocandins and amphotericin B in Candida glabrata isolates from a neutropenia patient with prolonged fungaemia

Cho, E., Shin, J. H., Kim, S. H., Kim, H., Park, J. S., Sung, H., Kim, M., & Im, H. J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku518 · Cited by 36 · see citing works

Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study

González, G. M., Treviño‐Rangel, R. D. J., Palma‐Nicolás, J. P., Martinez, C. R., González‐González, J. G., Ayala, J., Caballero, A., Morfín‐Otero, R., Rodríguez-Noriega, E., Velarde, F., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt283 · Cited by 35 · see citing works

Validation of 24-Hour Posaconazole and Voriconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Application of Epidemiological Cutoff Values to Results from a Global Candida Antifungal Surveillance Program

Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02437-10 · Cited by 34 · see citing works

Molecular Confirmation of the Relationship between Candida guilliermondii Fks1p Naturally Occurring Amino Acid Substitutions and Its Intrinsic Reduced Echinocandin Susceptibility

Dudiuk, C., Macedo, D., Leonardelli, F., Theill, L., Cabeza, M. S., Gamarra, S. P., & García‐Effrón, G. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02644-16 · Cited by 33 · see citing works

Clinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001-10

Chen, Y., Huang, S., Tang, J., Tsay, W., Yao, M., Ko, B., Chou, W., Tien, H., & Hsueh, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt214 · Cited by 31 · see citing works

Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China

Cheng, J.-W., Yu, S.-Y., Xiao, M., Wang, H., Kudinha, T., Kong, F., & Xu, Y. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00938-16 · Cited by 29 · see citing works

A case of Candida haemulonii osteitis: clinical features, biochemical characteristics, and antifungal resistance profile

Crouzet, J., Sotto, A., Picard, E., Lachaud, L., & Bourgeois, N. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03471.x · Cited by 28 · see citing works

Relationship between respiration deficiency and azole resistance in clinical Candida glabrata

Peng, Y., Dong, D., Jiang, C., Yu, B., Wang, X., & Ji, Y. (2012) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2012.00821.x · Cited by 27 · see citing works

Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: An experience in a tertiary hospital in mid-Taiwan

Tseng, T.-Y., Chen, T., Ho, C., Lin, P., Chou, C.-H., Tsai, C.-T., Wang, J.-H., Chi, C.-Y., & Ho, M. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2016.08.015 · Cited by 27 · see citing works

Candidaemia Observed at a University Hospital in Milan (Northern Italy) and Review of Published Studies from 2010 to 2014

Milazzo, L., Peri, A. M., Mazzali, C., Grande, R., Cazzani, C., Ricaboni, D., Castelli, A., Raimondi, F., Magni, C. F., Galli, M., et al. (2014) · Mycopathologia · doi:10.1007/s11046-014-9786-9 · Cited by 26 · see citing works

Pan-azole-Resistant Candida guilliermondii from a Leukemia Patient’s Silent Funguria

Savini, V., Catavitello, C., Marzio, I. D., Masciarelli, G., Astolfi, D., Balbinot, A., Bianco, A., Pompilio, A., Bonaventura, G. D., D’Amario, C., et al. (2010) · Mycopathologia · doi:10.1007/s11046-010-9278-5 · Cited by 24 · see citing works

Two echinocandin-resistant Candida glabrata FKS mutants from South Africa

Naicker, S. D., Magobo, R. E., Zulu, T. G., Maphanga, T. G., Luthuli, N., Lowman, W., & Govender, N. P. (2016) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2016.03.004 · Cited by 24 · see citing works

Neonatal Candidemia Caused by Candida haemulonii: Case Report and Review of Literature

Silva, C. M., Carvalho-Parahym, A. M. R., Macêdo, D. P. C., de Lima-Neto, R. G., Francisco, E. C., Melo, A. S. D. A., Silva, M. D. C. M., Jucá, M. B., de Mello, L. R. B., Amorim, R. J. M., et al. (2015) · Mycopathologia · doi:10.1007/s11046-015-9872-7 · Cited by 23 · see citing works

Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC

Saraya, T., Tanabe, K., Araki, K., Yonetani, S., Makino, H., Watanabe, T., Tsujimoto, N., Takata, S., Kurai, D., Ishii, H., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03593-13 · Cited by 22 · see citing works

Evaluation of the New Micronaut- Candida System Compared to the API ID32C Method for Yeast Identification

Szabó, Z., Tóth, B., Kovács, M., Kardos, G., Maráz, A., Rozgonyi, F., & Majoros, L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02350-07 · Cited by 22 · see citing works

Clinical Characteristics, Laboratory Identification, and In Vitro Antifungal Susceptibility of Yarrowia (Candida) lipolytica Isolates Causing Fungemia: a Multicenter, Prospective Surveillance Study

Zhao, Y. Y., Chan, J. F., Tsang, C., Wang, H., Guo, D., Pan, Y., Xiao, Y., Yue, N., Chen, J. H.-K., Lau, S. K. P., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01985-15 · Cited by 21 · see citing works

CAND-LO 2014–15 study: changing epidemiology of candidemia in Lombardy (Italy)

Prigitano, A., Cavanna, C., Passera, M., Ossi, C. M., Sala, E., Lombardi, G., Grancini, A., Luca, C. D., Bramati, S., Gelmi, M., et al. (2016) · Infection · doi:10.1007/s15010-016-0951-6 · Cited by 21 · see citing works

Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains

Denardi, L. B., Keller, J. T., Oliveira, V., Mario, D. A. N., Santúrio, J. M., & Alves, S. H. (2017) · Mycopathologia · doi:10.1007/s11046-017-0141-9 · Cited by 21 · see citing works

Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period

Pemán, J., Bosch, M., Cantón, E., Viudes, A., Jarque, I., García, M. G., García‐Martínez, J., & Gobernado, M. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.07.014 · Cited by 20 · see citing works

Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia

Imbert, S., Castain, L., Pons, A., Jacob, S., Meyer, I., Palous, M., Vézinet, C., Langeron, O., Hennequin, C., Monsel, A., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.07.025 · Cited by 18 · see citing works

Dose escalation studies with caspofungin against Candida glabrata

Domán, M., Kovács, R., Perlin, D. S., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., & Majoros, L. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000116 · Cited by 13 · see citing works

Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system

Cheng, J.-W., Liao, K., Kudinha, T., Yu, S.-Y., Xiao, M., Wang, H., Kong, F., & Xu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-01106-7 · Cited by 13 · see citing works

Rare occurrence of fatalCandida haemuloniiperitonitis in a diabetic CAPD patient

Yuvaraj, A., Rohit, A., Koshy, P. J., Nagarajan, P., Nair, S., & Abraham, G. (2014) · Renal Failure · doi:10.3109/0886022x.2014.944067 · Cited by 10 · see citing works

Development of Two Molecular Approaches for Differentiation of Clinically Relevant Yeast Species Closely Related to Candida guilliermondii and Candida famata

Feng, X., Wu, J., Ling, B., Yang, X., Liao, W., Pan, W., & Yao, Z. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01297-14 · Cited by 10 · see citing works

Candida guilliermondii continuous ambulatory peritoneal dialysis peritonitis confirmed by 16s rRNA sequencing

Kim, M., Bae, E. H., Kim, S. W., & Kwon, S. (2016) · Nephrology · doi:10.1111/nep.12650 · Cited by 2 · see citing works

Scientific Opinion on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA†

(BIOHAZ), E. P. O. B. H., Ricci, A., Allende, A., Bolton, D., Chemaly, M., Davies, R., Gironés, R., Herman, L., Koutsoumanis, K. P., Lindqvist, R., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4664 · Cited by 460 · see citing works

Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens

Friedman, D. Z. P., & Schwartz, I. S. (2019) · Journal of Fungi · doi:10.3390/jof5030067 · Cited by 357 · see citing works

Scientific Opinion on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA (2017–2019)

(BIOHAZ), E. P. O. B. H., Koutsoumanis, K., Allende, A., Alvarez‐Ordóñez, A., Bolton, D., Bover‐Cid, S., Chemaly, M., Davies, R., De Cesare, A., Hilbert, F., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.5966 · Cited by 294 · see citing works

Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities

Ahmad, S., & Alfouzan, W. (2021) · Microorganisms · doi:10.3390/microorganisms9040807 · Cited by 269 · see citing works

Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival

Hassan, Y., Chew, S. Y., & Than, L. T. L. (2021) · Journal of Fungi · doi:10.3390/jof7080667 · Cited by 170 · see citing works

Candida auris Outbreaks: Current Status and Future Perspectives

Gaetano, S. D., Midiri, A., Mancuso, G., Avola, M. G., & Biondo, C. (2024) · Microorganisms · doi:10.3390/microorganisms12050927 · Cited by 111 · see citing works

Environmental Clonal Spread of Azole-Resistant Candida parapsilosis with Erg11-Y132F Mutation Causing a Large Candidemia Outbreak in a Brazilian Cancer Referral Center

Thomaz, D. Y., de Almeida, J. N., Sejas, O. N. E., Negro, G. M. B. D., Carvalho, G. O. M. H., Gimenes, V. M. F., de Souza, M. E. B., Arastehfar, A. A., Camargo, C. H., Motta, A. L., et al. (2021) · Journal of Fungi · doi:10.3390/jof7040259 · Cited by 95 · see citing works

Antifungal Resistance in Candida auris: Molecular Determinants

Frías-De-León, M. G., Hernández-Castro, R., Vite-Garín, T., Arenas, R., Bonifaz, A., Castañón-Olivares, L., Acosta-Altamirano, G., & Martínez-Herrera, E. (2020) · Antibiotics · doi:10.3390/antibiotics9090568 · Cited by 93 · see citing works

Strategies to Prevent Transmission of Candida auris in Healthcare Settings

Ahmad, S., & Asadzadeh, M. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00451-7 · Cited by 84 · see citing works

Candida glabrata Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination

León, M. G. F.-D., Hernández‐Castro, R., Conde-Cuevas, E., García-Coronel, I. H., Vázquez-Aceituno, V. A., Soriano-Ursua, M. A., Farfán‐García, E. D., Ocharan-Hernández, M. E., Rodríguez‐Cerdeira, C., Arenas, R., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101529 · Cited by 78 · see citing works

Broad-spectrum antimicrobial activity of secondary metabolites produced by Serratia marcescens strains

Clements, T., Ndlovu, T., & Khan, W. (2019) · Microbiological Research · doi:10.1016/j.micres.2019.126329 · Cited by 77 · see citing works

Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates

Arastehfar, A. A., Daneshnia, F., Najafzadeh, M. J., Hagen, F., Mahmoudi, S., Salehi, M., Zarrinfar, H., Namvar, Z., Zareshahrabadi, Z., Khodavaisy, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00206 · Cited by 70 · see citing works

Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris

de Oliveira, H. C., Monteiro, M. C., Rossi, S. A., Pemán, J., Gaitán, A. C. R., Mendes‐Giannini, M. J. S., Mellado, E., & Zaragoza, Ó. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00083 · Cited by 67 · see citing works

Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections

Wambaugh, M. A., Denham, S. T., Ayala, M., Brammer, B., Stonhill, M. A., & Brown, J. C. (2020) · eLife · doi:10.7554/elife.54160 · Cited by 65 · see citing works

The effect of antifungal resistance development on the virulence of Candida species

Bohner, F., Papp, C., & Gácser, A. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac019 · Cited by 63 · see citing works

Screening the antifungal activities of monoterpenes and their isomers againstCandidaspecies

Iraji, A., Yazdanpanah, S., Alizadeh, F., Mirzamohammadi, S., Ghasemi, Y., Pakshir, K., Yang, Y., & Zomorodian, K. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14740 · Cited by 61 · see citing works

Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis

Padovan, A. C. B., Rocha, W. P. D. S., Toti, A. C. D. M., de Jesus, D. F. F., Chaves, G. M., & Colombo, A. L. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103267 · Cited by 54 · see citing works

Multidrug Resistance in Mammals and Fungi—From MDR to PDR: A Rocky Road from Atomic Structures to Transport Mechanisms

Khunweeraphong, N., & Kuchler, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094806 · Cited by 54 · see citing works

Clonality of Fluconazole-Nonsusceptible<i>Candida tropicalis</i>in Bloodstream Infections, Taiwan, 2011–2017

Chen, P.-Y., Chuang, Y.-C., Wu, U.-I., Sun, H.-Y., Wang, J.-T., Sheng, W.-H., Lo, H.-J., Wang, H.-Y., Chen, Y.-C., & Chang, S.-C. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2509.190520 · Cited by 51 · see citing works

The epidemiology of Candida species in the Middle East and North Africa

Ghazi, S., Rafei, R., Osman, M., El Safadi, D., Mallat, H., Papon, N., Dabboussi, F., Bouchara, J.-P., & Hamze, M. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.07.006 · Cited by 50 · see citing works

Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait

Al-Baqsami, Z. F., Ahmad, S., & Khan, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-63240-z · Cited by 50 · see citing works

Broad-spectrum antifungal activity of spirooxindolo-pyrrolidine tethered indole/imidazole hybrid heterocycles against fungal pathogens

Bolous, M., Arumugam, N., Almansour, A. I., Kumar, R. S., Maruoka, K., Antharam, V. C., & Thangamani, S. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.07.022 · Cited by 48 · see citing works

Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris

Dudiuk, C., Berrío, I., Leonardelli, F., Morales-López, S. E., Theill, L., Macedo, D., Rodríguez, J. Y., Salcedo, S., Marín, A., Gamarra, S. P., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz178 · Cited by 47 · see citing works

Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen

Mas, C. D., Rossato, L. L., Shimizu, T., Oliveira, E. B., da Silva, P. I., Meis, J. F. G. M., Colombo, A. L., & Hayashi, M. A. F. (2019) · Biomolecules · doi:10.3390/biom9060205 · Cited by 46 · see citing works

Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases

Shaw, T. D., Krasnodembskaya, A. D., Schroeder, G. N., Zumla, A. I., Maeurer, M. J., & O’Kane, C. M. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-21 · Cited by 42 · see citing works

Antifungal Development and the Urgency of Minimizing the Impact of Fungal Diseases on Public Health

de Oliveira, H. C., Bezerra, B. T., & Rodrigues, M. L. (2022) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.2c00055 · Cited by 41 · see citing works

Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin

Oliva, A., Rosa, F. G. D., Mikulska, M., Pea, F., Sanguinetti, M., Tascini, C., & Venditti, M. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2240956 · Cited by 40 · see citing works

Antimicrobial, Antivirulence, and Antiparasitic Potential of Capsicum chinense Jacq. Extracts and Their Isolated Compound Capsaicin

Menezes, R. D. P., Bessa, M. A. D. S., Siqueira, C. D. P., Teixeira, S. C., Ferro, E. A. V., Martins, M. M., Cunha, L. C. S., & Martins, C. H. G. (2022) · Antibiotics · doi:10.3390/antibiotics11091154 · Cited by 39 · see citing works

Retinoids in Fungal Infections: From Bench to Bedside

Cosio, T., Gaziano, R., Zuccari, G., Costanza, G., Grelli, S., Francesco, P. D., Bianchi, L., & Campione, E. (2021) · Pharmaceuticals · doi:10.3390/ph14100962 · Cited by 38 · see citing works

Antifungal susceptibility profiles of rare ascomycetous yeasts

Hansen, A. P., Lass‐Flörl, C., Lackner, M., Rare Yeast Study Group, Aigner, M., Alastruey‐Izquierdo, A., Arıkan-Akdağlı, S., Bader, O., Becker, K., Boekhout, T., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz231 · Cited by 38 · see citing works

Benzimidazole tethered pyrrolo[3,4-b]quinoline with broad-spectrum activity against fungal pathogens

Villa, P., Arumugam, N., Almansour, A. I., Kumar, R. S., Mahalingam, S. M., Maruoka, K., & Thangamani, S. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.01.006 · Cited by 37 · see citing works

Antifungal and Antibiofilm Activities of B-Type Oligomeric Procyanidins From Commiphora leptophloeos Used Alone or in Combination With Fluconazole Against Candida spp.

Dantas-Medeiros, R., Zanatta, A. C., de Souza, L. B. F. C., Fernandes, J. M., Amorim-Carmo, B., Torres-Rêgo, M., Fernandes‐Pedrosa, M. D. F., Vilegas, W., Araújo, T. A. D. S., Michel, S., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.613155 · Cited by 36 · see citing works

How urgent is the need for new antifungals?

Stewart, A. G., & Paterson, D. L. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1935868 · Cited by 36 · see citing works

Blood and intra-abdominal <i>Candida</i> spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in <i>Candida parapsilosis</i>, low echinocandin resistance and absence of <i>Candida auris</i>

Díaz-García, J., Gómez, A., Machado, M., Alcalá, L., Reigadas, E., Sánchez-Carrillo, C., Pérez-Ayala, A., Gómez-García De La Pedrosa, E., González-Romo, F., Cuétara, M. S., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac288 · Cited by 35 · see citing works

Increasing Prevalence of Multidrug-Resistant Candida haemulonii Species Complex among All Yeast Cultures Collected by a Reference Laboratory over the Past 11 Years

Lima, S. L., Francisco, E. C., de Almeida, J. N., Santos, D. W. D. C. L., Carlesse, F., Queiroz‐Telles, F., Melo, A. S. D. A., & Colombo, A. L. (2020) · Journal of Fungi · doi:10.3390/jof6030110 · Cited by 34 · see citing works

Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity

Ahmad, S., Khan, Z., Al‐Sweih, N., Alfouzan, W. A., Joseph, L., & Asadzadeh, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240426 · Cited by 33 · see citing works

Evaluation of antimicrobial activity of the hydrolate of Coridothymus capitatus (L.) Reichenb. fil. (Lamiaceae) alone and in combination with antimicrobial agents

Marino, A., Nostro, A., Mandras, N., Roana, J., Ginestra, G., Miceli, N., Taviano, M. F., Gelmini, F., Beretta, G., & Tullio, V. C. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-2877-x · Cited by 32 · see citing works

Cell wall mannan of Candida krusei mediates dendritic cell apoptosis and orchestrates Th17 polarization via TLR-2/MyD88-dependent pathway

Nguyen, T. N. Y., Padungros, P., Wongsrisupphakul, P., Sa‐Ard‐Iam, N., Mahanonda, R., Matangkasombut, O., Choo, M., & Ritprajak, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-35101-3 · Cited by 30 · see citing works

In vitro evaluation of the activity of an essential oil from Pistacia vera L. variety Bronte hull against Candida sp.

D’Arrigo, M., Bisignano, C., Irrera, P., Smeriglio, A., Zagami, R., Trombetta, D., Romeo, O., & Mandalari, G. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2425-0 · Cited by 30 · see citing works

Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections

Campos, L. D. A., Fin, M. T., dos Santos, K. S., Gualque, M. W. D. L., Cabral, A. K. L. F., Khalil, N. M., Fusco‐Almeida, A. M., Mainardes, R. M., & Mendes‐Giannini, M. J. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010266 · Cited by 29 · see citing works

Methods for identification of Candida auris, the yeast of global public health concern: A review

Mahmoudi, S., Afshari, S. A. K., Gharehbolagh, S. A., Mirhendi, H., & Makimura, K. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.04.004 · Cited by 28 · see citing works

Candida glabrata is a successful pathogen: An artist manipulating the immune response

Castrejón-Jiménez, N. S., Castillo-Cruz, J., Baltierra‐Uribe, S. L., Hernández-González, J. C., & Estela, G.-P. B. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127038 · Cited by 28 · see citing works

Yeast Species in the Oral Cavities of Older People: A Comparison between People Living in Their Own Homes and Those in Rest Homes

Thiyahuddin, N. M., Lamping, E., Rich, A. M., & Cannon, R. D. (2019) · Journal of Fungi · doi:10.3390/jof5020030 · Cited by 28 · see citing works

Invasive candidiasis

Rodrigues, L. S., Motta, F. D. A., Picharski, G. L., Vasconcelos, T. M., Ricieri, M. C., & Dalla-Costa, L. M. (2019) · Medicine · doi:10.1097/md.0000000000015933 · Cited by 28 · see citing works

New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species

Silva, L. N., de Mello, T. P., Ramos, L. S., Branquinha, M. H., & dos Santos, A. L. S. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191025152412 · Cited by 27 · see citing works

The High-Quality Complete Genome Sequence of the Opportunistic Fungal Pathogen Candida vulturna CBS 14366T

Navarro-Muñoz, J. C., de Jong, A. W., van den Ende, B. G., Haas, P., Then, E., Tap, R. M., Collemare, J., & Hagen, F. (2019) · Mycopathologia · doi:10.1007/s11046-019-00404-0 · Cited by 27 · see citing works

Synthesis, structural characterization and prospects for a new tris (5-methylbenzimidazole) tris (oxalato) ferrate(III) trihydrate complex as a promising antibacterial and antifungal agent

Essghaier, B., Dridi, R., Arouri, A., & Zid, M. F. (2021) · Polyhedron · doi:10.1016/j.poly.2021.115420 · Cited by 26 · see citing works

Yarrowia lipolytica causes sporadic cases and local outbreaks of infections and colonisation

Desnos‐Ollivier, M., Letscher‐Bru, V., Neuvéglise, C., & Dromer, F. (2020) · Mycoses · doi:10.1111/myc.13095 · Cited by 25 · see citing works

Anti-Candida Activity of Essential Oils from Lamiaceae Plants from the Mediterranean Area and the Middle East

Potente, G., Bonvicini, F., Gentilomi, G. A., & Antognoni, F. (2020) · Antibiotics · doi:10.3390/antibiotics9070395 · Cited by 25 · see citing works

Insights into the Multi-Azole Resistance Profile in Candida haemulonii Species Complex

Silva, L. N., Ramos, L. S., de Oliveira, S. S. C., Magalhães, L. B., Squizani, E. D., Kmetzsch, L., Vainstein, M. H., Branquinha, M. H., & dos Santos, A. L. S. (2020) · Journal of Fungi · doi:10.3390/jof6040215 · Cited by 25 · see citing works

Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for non-albicans Candida and uncommon yeast isolates

Teke, L., Barış, A., & Bayraktar, B. (2021) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2021.106232 · Cited by 25 · see citing works

Detection in Orchards of Predominant Azole-Resistant Candida tropicalis Genotype Causing Human Candidemia, Taiwan

Tseng, K., Chen, Y.-Z., Zhou, Z.-L., Tsai, J., Tseng, M.-N., Liu, H.-L., Wu, C., Liao, Y.-C., Lin, C.-C., Tsai, D.-J., et al. (2024) · Emerging infectious diseases · doi:10.3201/eid3011.240545 · Cited by 24 · see citing works

Superficial candidosis by Candida duobushaemulonii: An emerging microorganism

León, M. G. F.-D., Martínez-Herrera, E. O., Acosta‐Altamirano, G., Arenas, R. G., & Rodríguez‐Cerdeira, C. (2019) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2019.103960 · Cited by 24 · see citing works

Yeast communities of primary and secondary peat swamp forests in southern Thailand

Boonmak, C., Khunnamwong, P., & Limtong, S. (2019) · Antonie van Leeuwenhoek · doi:10.1007/s10482-019-01317-0 · Cited by 23 · see citing works

Exploration of yeast communities in fresh coconut, palmyra, and nipa palm saps and ethanol-fermenting ability of isolated yeasts

Limtong, S., Am-In, S., Kaewwichian, R., Kaewkrajay, C., & Jindamorakot, S. (2020) · Antonie van Leeuwenhoek · doi:10.1007/s10482-020-01479-2 · Cited by 22 · see citing works

Surface-Active Compounds Produced by Microorganisms: Promising Molecules for the Development of Antimicrobial, Anti-Inflammatory, and Healing Agents

Araújo, J. M. M., Monteiro, J. D. M., Silva, D. H. D. S., Alencar, A., Silva, K., Coelho, L., Pachêco, W. B., da Silva, D. F., Silva, M. J., da Silva, L. C. N., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11081106 · Cited by 22 · see citing works

Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature

Spiliopoulou, A., Kolonitsiou, F., Vrioni, G., Tsoupra, S., Lekkou, A., & Paliogianni, F. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101236 · Cited by 21 · see citing works

Evaluation of the potential virulence of Candida haemulonii species complex and Candida auris isolates in Caenorhabditis elegans as an in vivo model and correlation to their biofilm production capacity

Lima, S. L., Rossato, L. L., & Melo, A. S. D. A. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104461 · Cited by 20 · see citing works

Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients

Pietrobom, P. M. P., & Colombo, A. L. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000684 · Cited by 20 · see citing works

"In vivo" and "in vitro" antimicrobial activity of Origanum vulgare essential oil and its two phenolic compounds on clinical isolates of Candida spp.

Stringaro, A., Colone, M., Cecchetti, S., Zeppetella, E., Spadaro, F., & Angiolella, L. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-03355-1 · Cited by 19 · see citing works

Antimicrobial Activity of 4-Chlorocinnamic Acid Derivatives

Silva, R. H. N., Andrade, A. C. M., Nóbrega, D. F., de Castro, R. D., Pessôa, H. L. F., Rani, N., & de Sousa, D. P. (2019) · BioMed Research International · doi:10.1155/2019/3941242 · Cited by 19 · see citing works

Antifúngicos de uso sistémico

Quiles‐Melero, I., & García‐Rodríguez, J. (2021) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2021.04.004 · Cited by 18 · see citing works

Candida haemulonii Species Complex: A Mini-review

Francisco, E. C., de Jong, A. W., & Colombo, A. L. (2023) · Mycopathologia · doi:10.1007/s11046-023-00748-8 · Cited by 18 · see citing works

Systematic Review of Candidemia in Brazil: Unlocking Historical Trends and Challenges in Conducting Surveys in Middle-Income Countries

Hamburger, F. G., Gales, A. C., & Colombo, A. L. (2024) · Mycopathologia · doi:10.1007/s11046-024-00867-w · Cited by 18 · see citing works

Synergistic and antagonistic effects of immunomodulatory drugs on the action of antifungals against Candida glabrata and Saccharomyces cerevisiae

Tome, M., Zupan, J., Tomičić, Z., Matos, T., & Raspor, P. (2018) · PeerJ · doi:10.7717/peerj.4999 · Cited by 18 · see citing works

Candida glabrata Has No Enhancing Role in the Pathogenesis of Candida -Associated Denture Stomatitis in a Rat Model

Yano, J., Yu, A., Fidel, P. L., & Noverr, M. C. (2019) · mSphere · doi:10.1128/msphere.00191-19 · Cited by 18 · see citing works

Diazepam’s antifungal activity in fluconazole-resistant Candida spp. and biofilm inhibition in C. albicans: evaluation of the relationship with the proteins ALS3 and SAP5

da Silva, L. J., Barroso, F. D. D., Vieira, L. S., Mota, D. R. C., Firmino, B. K. D. S., da Silva, C. R., Cabral, V. P. D. F., Cândido, T. M., Sá, L. G. D. A. V., da Silva, W. M. B., et al. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001308 · Cited by 17 · see citing works

Microscopic fungi on the corpse – Promising tool requiring further research

Spychała, K., Piecuch, A., Szleszkowski, Ł., Kadej, M., & Ogórek, R. (2024) · Forensic Science International · doi:10.1016/j.forsciint.2024.112129 · Cited by 16 · see citing works

Antifungal and Anti-Inflammatory Potential of Bupleurum rigidum subsp. paniculatum (Brot.) H.Wolff Essential Oil

Zuzarte, M., Correia, P. M. P., Alves-Silva, J. M., Gonçalves, M. J., Cavaleiro, C., Cruz, M. T., & Salgueiro, L. (2021) · Antibiotics · doi:10.3390/antibiotics10050592 · Cited by 16 · see citing works

Chemical Profile, Anti-Microbial and Anti-Inflammaging Activities of Santolina rosmarinifolia L. Essential Oil from Portugal

Alves-Silva, J. M., Gonçalves, M. J., da Silva, A. B. G., Cavaleiro, C., Cruz, M. T., & Salgueiro, L. (2023) · Antibiotics · doi:10.3390/antibiotics12010179 · Cited by 16 · see citing works

Genomic evolution towards azole resistance in Candida glabrata clinical isolates unveils the importance of CgHxt4/6/7 in azole accumulation

Galocha, M., Viana, R., Pais, P., Silva-Dias, A., Cavalheiro, M., Miranda, I. M., Ende, M. V., Souza, C. S., Costa, C., Branco, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04087-0 · Cited by 15 · see citing works

An update on clinically relevant, rare, and emerging Candida and Saccharomycotina yeasts that have been recently reclassified from Candida

Francisco, E. C., Caceres, D. H., Brunelli, J. G. P., García‐Effrón, G., Arastehfar, A. A., Ribeiro, F. D. C., Almeida, M. N. D., Gonçalves, S. S., de Almeida, J. N., Lass‐Flörl, C., et al. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-23 · Cited by 15 · see citing works

Role of lizards as reservoirs of pathogenic yeasts of zoonotic concern

Rhimi, W., Mendoza‐Roldan, J. A., Aneke, C. I., Mosca, A., Otranto, D., Alastruey‐Izquierdo, A., & Cafarchia, C. (2022) · Acta Tropica · doi:10.1016/j.actatropica.2022.106472 · Cited by 15 · see citing works

Catestatin in innate immunity and Cateslytin-derived peptides against superbugs

Scavello, F., Mutschler, A., Hellé, S., Schneider, F., Chasserot‐Golaz, S., Strub, J., Cianférani, S., Haïkel, Y., & Metz‐Boutigue, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-94749-6 · Cited by 15 · see citing works

In vitro virulence determinants, comparative pathogenicity of Diutina (Candida) mesorugosa clinical isolates and literature review of the D. rugosa complex

Montoya, A. M., Luna-Rodríguez, C. E., Gracia-Robles, G., Rojas, O. C., Treviño‐Rangel, R. D. J., & González, G. M. (2019) · Mycologia · doi:10.1080/00275514.2019.1585161 · Cited by 14 · see citing works

Synergistic Antifungal Activity of Chito-Oligosaccharides and Commercial Antifungals on Biofilms of Clinical Candida Isolates

Ganan, M., Lorentzen, S. B., Gaustad, P., & Sørlie, M. (2021) · Journal of Fungi · doi:10.3390/jof7090718 · Cited by 14 · see citing works

Social, environmental and microbiologic aspects of endemic mycoses in Brazil

da Costa, M. C., de Sá, N. P., Johann, S., & Santos, D. A. (2019) · New Microbes and New Infections · doi:10.1016/j.nmni.2018.11.004 · Cited by 14 · see citing works

Opportunistic infections in pediatrics: when to suspect and how to approach

de Moraes‐Pinto, M. I., & Ferrarini, M. A. G. (2019) · Jornal de Pediatria · doi:10.1016/j.jped.2019.09.008 · Cited by 14 · see citing works

Molecular Diagnostic Advances in Transplant Infectious Diseases

Young, B. A., Hanson, K. E., & Gómez, C. A. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0704-7 · Cited by 14 · see citing works

Fruits are vehicles of drug-resistant pathogenic Candida tropicalis

Chen, Y.-Z., Tseng, K., Wang, S., Huang, C.-L., Lin, C.-C., Zhou, Z.-L., Tsai, D.-J., Lin, C.-M., Chen, Y.-L., Chen, K.-T., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01471-23 · Cited by 13 · see citing works

Population genomic analyses reveal high diversity, recombination and nosocomial transmission among Candida glabrata (Nakaseomyces glabrata) isolates causing invasive infections

Wang, Y., Xu, J., Abid, F. B., Salah, H., Sundararaju, S., Ismail, K. A., Wang, K., Matthew, L. S., Taj‐Aldeen, S. J., Ibrahim, E. B., et al. (2024) · Microbial Genomics · doi:10.1099/mgen.0.001179 · Cited by 13 · see citing works

Highly Specific and Rapid Multiplex Identification of Candida Species Using Digital Microfluidics Integrated with a Semi-Nested Genoarray

Mao, Z., Deng, A., Jin, X., Zhou, T., Zhang, S., Li, M., Lv, W., Huang, L., Zhong, H., Wang, S., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04265 · Cited by 13 · see citing works

Interaction Between Dendritic Cells and Candida krusei β-Glucan Partially Depends on Dectin-1 and It Promotes High IL-10 Production by T Cells

Dinh, T. T. H., Tummamunkong, P., Padungros, P., Ponpakdee, P., Boonprakong, L., Saisorn, W., Leelahavanichkul, A., Kueanjinda, P., & Ritprajak, P. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.566661 · Cited by 13 · see citing works

New 20-hydroxycholesterol-like compounds with fluorescent NBD or alkyne labels: Synthesis, in silico interactions with proteins and uptake by yeast cells

Faletrov, Y. V., Efimova, V. S., Horetski, M. S., Tugaeva, K. V., Frolova, N. S., Lin, Q., Isaeva, L. V., Rubtsov, M. A., Sluchanko, N. N., Novikova, L. A., et al. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.104850 · Cited by 11 · see citing works

Multiplex size marker (YEAST PLEX) for rapid and accurate identification of pathogenic yeasts

Aboutalebian, S., Mahmoudi, S., Charsizadeh, A., Nikmanesh, B., Rizi, M. H., & Mirhendi, H. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24370 · Cited by 11 · see citing works

Production of IgY against iron permease Ftr1 from Candida albicans and evaluation of its antifungal activity using Galleria mellonella as a model of systemic infection

de Souza, P. C., Corrêa, A. E. D. N., Gameiro, J. G., de Oliveira, A. G., Panagio, L. A., Venâncio, E. J., & Almeida, R. S. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106166 · Cited by 11 · see citing works

Existing and emerging therapies for the treatment of invasive candidiasis and candidemia

Bels, D. D., Maillart, E., Françoise Van Bambeke, A., Redant, S., & Honoré, P. M. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2142207 · Cited by 11 · see citing works

The Metschnikowia pulcherrima Clade as a Model for Assessing Inhibition of Candida spp. and the Toxicity of Its Metabolite, Pulcherrimin

Kręgiel, D., Czarnecka, K. H., Schusterová, H., Vadkertiová, R., & Nowak, A. (2023) · Molecules · doi:10.3390/molecules28135064 · Cited by 11 · see citing works

Cost–Benefit and Cost–Utility Analysis of Amphotericin B Supplementation of Corneal Storage Media With Endothelial Keratoplasty-Prepared Tissue

Chiang, T. T.-K., Shtein, R. M., McCoy, K. E., Hurlbert, S., & Grossman, G. (2019) · Cornea · doi:10.1097/ico.0000000000002242 · Cited by 11 · see citing works

Detection and Control of Fungal Outbreaks

Caceres, D. H., Tap, R. M., Alastruey‐Izquierdo, A., & Hagen, F. (2020) · Mycopathologia · doi:10.1007/s11046-020-00494-1 · Cited by 11 · see citing works

A Comprehensive Review of Identification Methods for Pathogenic Yeasts: Challenges and Approaches

Morovati, H., Kord, M., Ahmadikia, K., Eslami, S., Hemmatzadeh, M., Kurdestani, K. M., Khademi, M., & Darabian, S. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_375_22 · Cited by 10 · see citing works

Epidemiology of Candidemia, Candiduria and Emerging Candidozyma (Candida) auris Across Gulf Cooperative Council Countries and Yemen in the Arabian Peninsula

Ahmad, S., Boekhout, T., Al‐Hatmi, A. M. S., Al‐Harrasi, A., Khateb, A. M., Dhaheri, F. A. A., Shuraym, H. B., Thomsen, J., Alobaid, K., Asadzadeh, M., et al. (2025) · Mycoses · doi:10.1111/myc.70073 · Cited by 10 · see citing works

A review of medicinal plants used in the Brazilian Cerrado for the treatment of fungal and bacterial infections

da Cruz, J. E. R., Saldanha, H. C., Freitas, G. R. O. E., & Morais, E. R. (2021) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2021.100523 · Cited by 10 · see citing works

Anti‐ Candida, docking studies, and in vitro metabolism‐mediated cytotoxicity evaluation of Eugenol derivatives

Dutra, J. A. P., Maximino, S. C., Gonçalves, R. D. C. R., Morais, P. A. B., Silva, W. C. D. L., Rodrigues, R. P., Neto, Á. C., Lacerda, V., Borges, W. D. S., & Kitagawa, R. R. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14131 · Cited by 10 · see citing works

The effect of glucose and human serum on 5-aminolevulinic acid mediated photodynamic inactivation of Candida albicans

Maliszewska, I. H., Wawrzyńczyk, D., & Wanarska, E. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2019.101623 · Cited by 10 · see citing works

Anacardiaceae Family: Effect of Isolated Compounds and Other Identified Phytochemicals Against Clinically Relevant Candida Species—A Short Review

Guerra, R. N. M., Oliveira, A. D. S., Farias, J. R., Franco, D. C. G., Santos, P. G., Barbosa, N. T., Muniz, S. B., Abreu, A. G., & do Nascimento, F. R. F. (2025) · Antibiotics · doi:10.3390/antibiotics14030308 · Cited by 9 · see citing works

Unambiguous determination of farnesol and tyrosol in vaginal fluid using fast and sensitive UHPLC-MS/MS method

Pilařová, V., Vlčková, H., Jung, O., Protti, M., Buchta, V., Mercolini, L., Švec, F., & Nováková, L. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02699-1 · Cited by 9 · see citing works

A brief review on heterocyclic compounds with promising antifungal activity against Candida species

Korol', �. N., Molnar-babilya, D., Slivka, M. V., & Onysko, M. Y. (2022) · Organic Communications · doi:10.25135/acg.oc.141.2210.2609 · Cited by 8 · see citing works

Susceptibility of uncommon Candida species to systemic antifungals by the EUCAST methodology

Díaz-García, J., Alcalá, L., Martín‐Rabadán, P., Mesquida, A., Sánchez‐Carrillo, C., Reigadas, E., Muñóz, P., Escribano, P., & Guinea, J. (2019) · Medical Mycology · doi:10.1093/mmy/myz121 · Cited by 8 · see citing works

Liver abscess caused by Candida haemulonii var. vulnera. First case report in Peru

Pérez‐Lazo, G., Morales-Moreno, A., Soto‐Febres, F., Hidalgo, J. A. M., Neyra, E., & Bustamante, B. (2021) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2020.12.001 · Cited by 8 · see citing works

The Candida auris Alert: Facts and Perspectives

Lamoth, F., & Kontoyiannis, D. P. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix597 · Cited by 95 · see citing works

Candida auris—the growing menace to global health

Lone, S. A., & Ahmad, A. (2019) · Mycoses · doi:10.1111/myc.12904 · Cited by 210 · see citing works

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750 · see citing works

Candida auris : An emerging multidrug-resistant pathogen of global significance

Khan, Z., & Ahmad, S. (2017) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2017.11.004 · Cited by 23 · see citing works

Candida auris : A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen

Sekyere, J. O. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.578 · Cited by 307 · see citing works